Apoptotic endonuclease EndoG inhibits telomerase activity and induces malignant transformation of human CD4+ T cells


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Telomerase activity is regulated by an alternative splicing of mRNA of the telomerase catalytic subunit hTERT (human telomerase reverse transcriptase). Increased expression of the inactive spliced hTERT results in inhibition of telomerase activity. Little is known about the mechanism of hTERT mRNA alternative splicing. This study was aimed at determining the effect of an apoptotic endonuclease G (EndoG) on alternative splicing of hTERT and telomerase activity in CD4+ human T lymphocytes. Overexpression of EndoG in CD4+ T cells downregulated the expression of the active fulllength hTERT variant and upregulated the inactive alternatively spliced variant. Reduction of full-length hTERT levels caused downregulation of the telomerase activity, critical telomere shortening during cell division that converted cells into the replicative senescence state, activation of apoptosis, and finally cell death. Some cells survive and undergo a malignant transformation. Transformed cells feature increased telomerase activity and proliferative potential compared to the original CD4+ T cells. These cells have phenotype of T lymphoblastic leukemia cells and can form tumors and cause death in experimental mice.

Sobre autores

D. Vasina

Ecological Faculty

Email: zhdanovdd@mail.ru
Rússia, Moscow, 117198

D. Zhdanov

Ecological Faculty; Institute of Biomedical Chemistry

Autor responsável pela correspondência
Email: zhdanovdd@mail.ru
Rússia, Moscow, 117198; Moscow, 119121

E. Orlova

Institute of Theoretical and Experimental Biophysics

Email: zhdanovdd@mail.ru
Rússia, Pushchino, Moscow Region, 142290

V. Orlova

Ecological Faculty

Email: zhdanovdd@mail.ru
Rússia, Moscow, 117198

M. Pokrovskaya

Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Rússia, Moscow, 119121

S. Aleksandrova

Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Rússia, Moscow, 119121

N. Sokolov

Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Rússia, Moscow, 119121


Declaração de direitos autorais © Pleiades Publishing, Ltd., 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies